Assignee
LAB FRANCAIS DU FRACTIONNEMENT
FR·54 granted patents·59 pending applications·165 citations·filing 1998–2025
Top patents by PatentIndex Score
113 records- 0194US7579170B2Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIIILAB FRANCAIS DU FRACTIONNEMENT·Filed 2001·Granted Aug 25, 2009·44 cites·9 claims
- 0290US9873745B2Antibody method for treatment of a disease in which the target cells are cells which express CD20LAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 23, 2018·7 cites·17 claims
- 0388USRE45992EOptimized FC variantsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2010·Granted May 3, 2016·15 cites·10 claims
- 0487US10363496B2Method for purification of monoclonal antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jul 30, 2019·11 cites·13 claims
- 0587US10034921B2Proteins with modified glycosylation and methods of production thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 31, 2018·8 cites·14 claims
- 0684US7541029B2Anti-rhesus D monoclonal antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2006·Granted Jun 2, 2009·4 cites·4 claims
- 0781US10611826B2Affinity chromatography matrixLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Apr 7, 2020·4 cites·17 claims
- 0881US10174110B2Highly galactosylated anti-TNF-α antibodies and uses thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jan 8, 2019·4 cites·20 claims
- 0980US11091552B2Specific binding molecule directed against galectin-3 proteinLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Granted Aug 17, 2021·4 cites·17 claims
- 1080US8383104B2Thrombin-free biological adhesive and use thereof as a medicamentLAB FRANCAIS DU FRACTIONNEMENT·Filed 2006·Granted Feb 26, 2013·3 cites·22 claims
- 1179US9212215B2Treatment of bleeding with low half-life fibrinogenLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Dec 15, 2015·2 cites·14 claims
- 1278US6932969B1Ig fractions having immunomodulatory activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2000·Granted Aug 23, 2005·22 cites·13 claims
- 1377US9708409B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 18, 2017·1 cites·16 claims
- 1477US9358275B2Factor VII compositionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jun 7, 2016·2 cites·19 claims
- 1576US9718890B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Aug 1, 2017·1 cites·20 claims
- 1675US12025539B2Sampling device for sampling from a surface of an industrial vessel without requiring a person to descend into an industrial vessel, using a swabLAB FRANCAIS DU FRACTIONNEMENT·Filed 2019·Granted Jul 2, 2024·2 cites·20 claims
- 1775US10364425B2Recombinant or transgenic factor VII composition, each factor VII molecule having two N-glycosylation sites with defined glycan unitsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Jul 30, 2019·2 cites·11 claims
- 1875US9718889B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Aug 1, 2017·1 cites·27 claims
- 1975US9551009B2Transcription unit and use thereof in expression vectorsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2012·Granted Jan 24, 2017·3 cites·8 claims
- 2075US7727743B2Method for stabilizing a cryoprecipitate of plasmatic proteins for being subjected to a viral inactivation thermal treatmentLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Granted Jun 1, 2010·9 cites·18 claims
- 2174US9463241B2Method for stabilising an immunoglobulin G composition in liquid formLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Oct 11, 2016·1 cites·16 claims
- 2271US10611843B2Anti-CD303 monoclonal antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted Apr 7, 2020·1 cites·18 claims
- 2369US10081683B2Monoclonal antibodies with enhanced ADCC functionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2017·Granted Sep 25, 2018·0 cites·14 claims
- 2468USRE46585EOptimized FC variantsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2010·Granted Oct 24, 2017·1 cites·22 claims
- 2568US9700603B2Use of antidotes to coagulation inhibitors indicated in the prevention or treatment of thromboembolic pathologiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 11, 2017·1 cites·16 claims
- 2668US2023265155A1Fc mutants with modified functional activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2023·Application pending·0 cites
- 2764US12281312B2Anti-fibrinogen aptamersLAB FRANCAIS DU FRACTIONNEMENT·Filed 2021·Granted Apr 22, 2025·0 cites·9 claims
- 2863US9611311B2Albumin-purification method comprising a nanofiltration step, solution, and composition for therapeutic use containing the sameLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Apr 4, 2017·1 cites·13 claims
- 2962US9962431B2Treatment of bleeding with low half-life fibrinogenLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted May 8, 2018·0 cites·14 claims
- 3062US2020277385A1Anti-CD303 Monoclonal AntibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2020·Application pending·0 cites
- 3162US2025092150A1Fc polypeptide variants having an increased half-lifeLAB FRANCAIS DU FRACTIONNEMENT·Filed 2024·Application pending·0 cites
- 3261US9109020B2Use of ADCC-optimized antibodies for treating weak patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Granted Aug 18, 2015·0 cites·10 claims
- 3360US2020331994A1Oral composition of anti-tnf alpha antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2019·Application pending·0 cites
- 3460US2025243495A1Anti-Fibrinogen AptamersLAB FRANCAIS DU FRACTIONNEMENT·Filed 2025·Application pending·0 cites
- 3559US7790399B2Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptorsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2004·Granted Sep 7, 2010·1 cites·13 claims
- 3658US2010323368A1Cytokine production-inducing antibodyLAB FRANCAIS DU FRACTIONNEMENT·Filed 2009·Application pending·0 cites
- 3757US2009081216A1Treatment of pathologies which escape the immune response, using optimized antibodiesLAB FRANCAIS DU FRACTIONNEMENT·Filed 2008·Application pending·0 cites
- 3857US2019254276A1Glycols as pathogen inactivating agentsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 3956US7595165B2Method of measuring activation of effector cellsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2003·Granted Sep 29, 2009·2 cites·1 claims
- 4056US2019309058A1Highly galactosylated anti-tnf-alpha antibodies and uses thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 4155US9968662B2Factor VII compositionLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted May 15, 2018·0 cites·19 claims
- 4255US2019309057A1Highly galactosylated anti-tnf-alpha antibodies and uses thereofLAB FRANCAIS DU FRACTIONNEMENT·Filed 2018·Application pending·0 cites
- 4354US9879089B2Use of ADCC-optimized antibodies for treating low-responder patientsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Jan 30, 2018·0 cites·14 claims
- 4453US9850477B2Method for purifying active GLA-domain coagulation proteinsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2015·Granted Dec 26, 2017·0 cites·13 claims
- 4553US2019375835A1Use of monoclonal antibodies for the treatment of inflammation and bacterial infectionsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2019·Application pending·0 cites
- 4652US10239946B2Cell line overexpressing human CD303 antigenLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted Mar 26, 2019·0 cites·14 claims
- 4752US2016185847A1Use of monoclonal antibodies for the treatment of inflammation and bacterial infectionsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2013·Application pending·0 cites
- 4851US11649271B2Fc mutants with modified functional activityLAB FRANCAIS DU FRACTIONNEMENT·Filed 2016·Granted May 16, 2023·0 cites·24 claims
- 4951US11254920B2Factor VII composition having a substantially homogenous isoelectric pointLAB FRANCAIS DU FRACTIONNEMENT·Filed 2020·Granted Feb 22, 2022·0 cites·10 claims
- 5051US10364424B2Factor X mutantsLAB FRANCAIS DU FRACTIONNEMENT·Filed 2014·Granted Jul 30, 2019·0 cites·7 claims
Showing the top 50 of 113 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when LAB FRANCAIS DU FRACTIONNEMENT files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →